A Study of Patient Adherence and Convenience to Immunosuppressive Agents in Newly Liver Transplant

Inclusion Criteria: * Patient has been fully informed and has signed an IRB approved informed consent form within 7 days (Day 7-13) prior to POD 15 and is willing and able to follow study procedure * Patient is a primary liver transplant recipient * Patient is 20 to 70 years of age * Patient should be clearly conscious, fully understand and able to answer questionnaire Exclusion Criteria: * Patient has previously received or is receiving an organ transplant other than a liver. * Patient currently requires dialysis * Recipient or donor is known to be seropositive for human immunodeficiency virus (HIV) * Patient has received a liver transplant from a non-heart beating donor * Patient who is HCV negative has received an HCV positive (HCV RNA by PCR or HCV antibody) donor liver * Patient who is HbsAg negative has received an HbsAg positive (HBV DNA by PCR or HBV antibody) donor liver * Patient has received a liver transplant from a decrease donor \> 70 years of age * Patient has a current malignancy or a history of malignancy (within the past 5 years), except hepatocellular carcinoma within UCSF Criteria and basal or non-metastatic squamous cell carcinoma of skin that has been treated successfully. * Patient is hemodynamically unstable on POD 15